J 2025

Financial Volatility and Investment Dynamics in the Pharmaceutical Sector: Evidence from the Covid-19 Pandemic

KALAMEN, Kristián; František POLLÁK; Roman VAVREK; Petra PÁRTLOVÁ; Mónica GARCÍA-MELÓN et al.

Basic information

Original name

Financial Volatility and Investment Dynamics in the Pharmaceutical Sector: Evidence from the Covid-19 Pandemic

Authors

KALAMEN, Kristián; František POLLÁK; Roman VAVREK; Petra PÁRTLOVÁ and Mónica GARCÍA-MELÓN

Edition

Polish Journal of Management Studies, 2025, 2081-7452

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

50200 5.2 Economics and Business

Country of publisher

Poland

Confidentiality degree

is not subject to a state or trade secret

References:

Impact factor

Impact factor: 1.100 in 2024

Marked to be transferred to RIV

Yes

RIV identification code

RIV/75081431:_____/25:00002897

Organization unit

Institute of Technology and Business in České Budějovice

Keywords in English

pharmaceutical sector; covid-19; stock market volatility; investment risk; financial resilience

Tags

Changed: 25/7/2025 07:41, Ing. Barbora Langšádlová

Abstract

In the original language

This study aims to analyze the financial impact of the COVID-19 pandemic on the pharmaceutical sector by assessing market volatility, stock performance, and investment behavior across different pandemic waves. It provides a novel perspective by examining the different financial responses of major pharmaceutical companies, Johnson and Johnson, Pfizer, and Moderna, over 949 trading days (March 2019-December 2022). Using statistical tools such as standard deviation and kurtosis, the study identifies volatility patterns and extreme price movements before, during, and after the pandemic. The results show that the first and fourth waves had the highest market volatility, influenced by vaccine development, regulatory decisions and changing investor sentiment. While short-term financial gains were significant, long-term profitability was challenged by market corrections and policy constraints. This study contributes to the literature by providing insights into crisis-driven financial instability and highlights the need for risk aware investment strategies in the pharmaceutical sector.

Files attached

separat_-_Pollak__Partlova__IDUPS25005.pdf
Request the author's version of the file